Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.
- DOI
- 10.3390/ijms231911893
- Published
- 2022 Oct 6
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms231911893,
title = {Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.},
author = {Oxombre B and Madouri F and Journé AS and Ravez S and Woitrain E and Odou P and Duhal N and Ninni S and Montaigne D and Delhem N and Vermersch P and Melnyk P},
year = {2022},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms231911893},
url = {https://doi.org/10.3390/ijms231911893}
}RIS
TY - JOUR TI - Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. AU - Oxombre B AU - Madouri F AU - Journé AS AU - Ravez S AU - Woitrain E AU - Odou P AU - Duhal N AU - Ninni S AU - Montaigne D AU - Delhem N AU - Vermersch P AU - Melnyk P PY - 2022 JO - International journal of molecular sciences DO - 10.3390/ijms231911893 UR - https://doi.org/10.3390/ijms231911893 ER -
APA
B, O., F, M., AS, J., S, R., E, W., P, O., N, D., S, N., D, M., N, D., P, V., & P, M. (2022). Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.. International journal of molecular sciences. https://doi.org/10.3390/ijms231911893
Source records
- pubmed · retrieved 2026-09-26T14:07:41.647Z